May 24th, 2022 (Earnings Report)Dear Reader,Our scanners just identified several healthtech stocks that are expected to release earnings starting today, May 25th.If you are interested in any of these companies, we encourage you to do your own research and due diligence before pursuing any investments.Keep in mind, the actual earnings date and time may change, so if you’re interested in any of these companies you will need to pay close attention to their announcements.
Align Tech
Symbol: ALGN
Recent Price: $252.07
Average Analyst Price Target: $380.00 (51.50%)
Market Cap: $19.86B
Last Year's EPS: $3.04
Consensus EPS Forecast: $2.23
Expected Earnings Date: Jul 26 2022
Recent Analyst Action: Jason Bednar, analyst at Piper Sandler, reiterates coverage on Align Tech (ALGN) in the Healthcare sector with a Buy rating and a price target of $ 370 (4 days ago).
TipRanks.com also reports that Align Tech currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $380.00 . The target pricing ranges from a high forecast of $450.00 down to a low forecast of $310.00. Align Tech (ALGN)’s last closing price was $252.07 which would put the average price target at 51.50% upside.Here are 3rd party ratings for ALGN:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Strong Sell, Top 38% (95 out of 252)
--------------------------------------------------------------------------
Boston Scientific
Symbol: BSX
Recent Price: $38
Average Analyst Price Target: $46.86 (23.32%)
Market Cap: $54.32B
Last Year's EPS: $0.4
Consensus EPS Forecast: $0.42
Expected Earnings Date: Jul 26 2022
Recent Analyst Action: Pito Chickering, analyst at Deutsche Bank, reiterates coverage on Boston Scientific (BSX) in the Healthcare sector with a Hold rating and a price target of $ 45 (5 days ago).
TipRanks.com also reports that Boston Scientific currently has 14 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $46.86 . The target pricing ranges from a high forecast of $50.00 down to a low forecast of $43.00. Boston Scientific (BSX)’s last closing price was $38 which would put the average price target at 23.32% upside.Here are 3rd party ratings for BSX:
- TipRanks.com: Strong Buy
- TradingView.com: n/a
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 32% (81 out of 252)
--------------------------------------------------------------------------
Icon
Symbol: ICLR
Recent Price: $223.35
Average Analyst Price Target: $274.00 (22.68%)
Market Cap: $18.16B
Last Year's EPS: $2.12
Consensus EPS Forecast: $2.8
Expected Earnings Date: Jul 26 2022
Recent Analyst Action: Justin Bowers, analyst at Deutsche Bank, reiterates coverage on Icon (ICLR) in the Healthcare sector with a Buy rating and a price target of $ 285 (1 week ago).
TipRanks.com also reports that Icon currently has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $274.00 . The target pricing ranges from a high forecast of $315.00 down to a low forecast of $245.00. Icon (ICLR)’s last closing price was $223.35 which would put the average price target at 22.68% upside.Here are 3rd party ratings for ICLR:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Hold, Top 35% (89 out of 252)
--------------------------------------------------------------------------
Merit Medical Systems
Symbol: MMSI
Recent Price: $54.22
Average Analyst Price Target: $73.67 (35.87%)
Market Cap: $3.07B
Last Year's EPS: $0.62
Consensus EPS Forecast: $0.58
Expected Earnings Date: Jul 26 2022
Recent Analyst Action: Michael Petusky, analyst at Barrington, reiterates coverage on Merit Medical Systems (MMSI) in the Healthcare sector with a Buy rating and a price target of $ 78 (1 week ago).
TipRanks.com also reports that Merit Medical Systems currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $73.67 . The target pricing ranges from a high forecast of $78.00 down to a low forecast of $70.00. Merit Medical Systems (MMSI)’s last closing price was $54.22 which would put the average price target at 35.87% upside.Here are 3rd party ratings for MMSI:
- TipRanks.com: Strong Buy
- TradingView.com: Neutral
- Yahoo! Finance: Neutral Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 38% (95 out of 252)
--------------------------------------------------------------------------
Option Care Health
Symbol: OPCH
Recent Price: $32.34
Average Analyst Price Target: $35.75 (10.54%)
Market Cap: $5.82B
Last Year's EPS: $0.18
Consensus EPS Forecast: $0.23
Expected Earnings Date: Jul 26 2022
Recent Analyst Action: Michael Petusky, analyst at Barrington, reiterates coverage on Option Care Health (OPCH) in the Healthcare sector with a Buy rating and a price target of $ 33 (1 month ago).
TipRanks.com also reports that Option Care Health currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $35.75 . The target pricing ranges from a high forecast of $39.00 down to a low forecast of $33.00. Option Care Health (OPCH)’s last closing price was $32.34 which would put the average price target at 10.54% upside.Here are 3rd party ratings for OPCH:
- TipRanks.com: Strong Buy
- TradingView.com: Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Strong buy
- Zacks.com: Hold, Bottom 44% (140 out of 252)
--------------------------------------------------------------------------
Viking Therapeutics
Symbol: VKTX
Recent Price: $3.29
Average Analyst Price Target: $15.33 (365.96%)
Market Cap: $254.56M
Last Year's EPS: -$0.2
Consensus EPS Forecast: -$0.21
Expected Earnings Date: Jul 26 2022
Recent Analyst Action: Naz Rahman, analyst at Maxim Group, reiterates coverage on Viking Therapeutics (VKTX) in the Healthcare sector with a Buy rating and a price target of $ 10 (1 week ago).
TipRanks.com also reports that Viking Therapeutics currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $15.33 . The target pricing ranges from a high forecast of $21.00 down to a low forecast of $10.00. Viking Therapeutics (VKTX)’s last closing price was $3.29 which would put the average price target at 365.96% upside.Here are 3rd party ratings for VKTX:
- TipRanks.com: Strong Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: hold
- Zacks.com: Hold, Top 29% (72 out of 252)
--------------------------------------------------------------------------
To Your Financial Future,
The Editor, HealthTechMovers.com
